Literature DB >> 19053978

Ethanol exposure impairs LPS-induced pulmonary LIX expression: alveolar epithelial cell dysfunction as a consequence of acute intoxication.

James E Walker1, Anthony R Odden, Samithamby Jeyaseelan, Ping Zhang, Gregory J Bagby, Steve Nelson, Kyle I Happel.   

Abstract

BACKGROUND: Alcohol intoxication impairs innate immune responses to bacterial pneumonia, including neutrophil influx. Lipopolysaccharide (LPS)-induced chemokine (LIX or CXCL5) is a recently described chemokine produced by type-II alveolar epithelial (AE2) cells which facilitates neutrophil recruitment. The effect of acute alcohol intoxication on AE2 cell expression of LIX is unknown.
METHODS: C57BL/6 mice were given an intraperitoneal (i.p.) injection of ethanol (4 g/kg) or saline 30 minutes prior to intratracheal (i.t.) injection with 10 mug Escherichia coli LPS. In vitro stimulation of primary AE2 cells or murine AE2 cell line MLE-12 was performed with LPS and tumor necrosis factor-alpha (TNF-alpha).
RESULTS: LIX protein is readily detectable in the lung but not in plasma following LPS administration, demonstrating "compartmentalization" of this chemokine during pulmonary challenge. In contrast to the CXC chemokines keratinocyte-derived chemokine and macrophage inflammatory protein-2, which are abundantly expressed in both lung tissue and alveolar macrophages, LIX expression is largely confined to the lung parenchyma. Compared to controls, intoxicated animals show a decrease in LIX and neutrophil number in bronchoalveolar lavage fluid following LPS challenge. Ethanol inhibits LIX at the transcriptional level. In vitro studies show that LPS and TNF-alpha are synergistic in inducing LIX by either primary AE2 or MLE-12 cells. Acute ethanol exposure potently and dose-dependently inhibits LIX expression by AE2 cells. Activation of nuclear factor-kappaB is critical to LIX expression in MLE-12 cells, and acute ethanol treatment interferes with early activation of this pathway as evidenced by impairing phosphorylation of p65 (RelA). Inhibition of p38 mitogen-activated protein kinase signaling, but not ERK1/2 activity, in MLE-12 cells by acute alcohol is likely an important cause of decreased LIX expression during challenge.
CONCLUSIONS: These data demonstrate direct suppression of AE2 cell innate immune function by ethanol and add to our understanding of the mechanisms by which acute intoxication impairs the lung's response to microbial challenge.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053978      PMCID: PMC2646113          DOI: 10.1111/j.1530-0277.2008.00844.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  42 in total

1.  TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes.

Authors:  Shilpa Oak; Pranoti Mandrekar; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

2.  Alcohol intoxication inhibits pulmonary S100A8 and S100A9 expression in rats challenged with intratracheal lipopolysaccharide.

Authors:  Ping Zhang; Qiu Zhong; Gregory J Bagby; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2007-01       Impact factor: 3.455

3.  Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10.

Authors:  Pranoti Mandrekar; Donna Catalano; Bernadette White; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2006-01       Impact factor: 3.455

4.  Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes.

Authors:  Yvonne Drechsler; Angela Dolganiuc; Oxana Norkina; Laszlo Romics; Weibo Li; Karen Kodys; Fritz H Bach; Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

5.  Hypoxia-induced mitogenic factor promotes vascular adhesion molecule-1 expression via the PI-3K/Akt-NF-kappaB signaling pathway.

Authors:  Qiangsong Tong; Liduan Zheng; Li Lin; Bo Li; Danming Wang; Dechun Li
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-18       Impact factor: 6.914

6.  Functions and regulation of NF-kappaB RelA during pneumococcal pneumonia.

Authors:  Lee J Quinton; Matthew R Jones; Benjamin T Simms; Mariya S Kogan; Bryanne E Robson; Shawn J Skerrett; Joseph P Mizgerd
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

7.  Acute alcohol intake impairs lung inflammation by changing pro- and anti-inflammatory mediator balance.

Authors:  Nympha B D'Souza El-Guindy; Willem J de Villiers; Dennis E Doherty
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

8.  Acute alcohol intoxication suppresses the pulmonary ELR-negative CXC chemokine response to lipopolysaccharide.

Authors:  Kyle I Happel; Xiaowen Rudner; Lee J Quinton; Jennifer L Movassaghi; Charles Clark; Anthony R Odden; Ping Zhang; Gregory J Bagby; Steve Nelson; Judd E Shellito
Journal:  Alcohol       Date:  2007-08       Impact factor: 2.405

9.  Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide.

Authors:  Yan Sun; Todd Fox; Gautam Adhikary; Mark Kester; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2008-04-17       Impact factor: 4.962

10.  Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation.

Authors:  Marcus Gereke; Lothar Gröbe; Silvia Prettin; Michael Kasper; Stefanie Deppenmeier; Achim D Gruber; Richard I Enelow; Jan Buer; Dunja Bruder
Journal:  Respir Res       Date:  2007-07-04
View more
  9 in total

1.  Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: role of protein phosphatases.

Authors:  Heng Ma; Lu Yu; Emily A Byra; Nan Hu; Kyoko Kitagawa; Keiichi I Nakayama; Toshihiro Kawamoto; Jun Ren
Journal:  J Mol Cell Cardiol       Date:  2010-04-01       Impact factor: 5.000

2.  Alcohol suppresses the granulopoietic response to pulmonary Streptococcus pneumoniae infection with enhancement of STAT3 signaling.

Authors:  Robert W Siggins; John N Melvan; David A Welsh; Gregory J Bagby; Steve Nelson; Ping Zhang
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

Review 3.  Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model.

Authors:  Nympha B D'Souza El-Guindy; Elizabeth J Kovacs; Philippe De Witte; Claudia Spies; John M Littleton; Willem J S de Villiers; Amanda J Lott; Timothy P Plackett; Nadine Lanzke; Gary G Meadows
Journal:  Alcohol Clin Exp Res       Date:  2010-06-25       Impact factor: 3.455

4.  Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.

Authors:  Ram R Patlolla; Mahavir Chougule; Apurva R Patel; Tanise Jackson; Prasad N V Tata; Mandip Singh
Journal:  J Control Release       Date:  2010-02-11       Impact factor: 9.776

Review 5.  Mechanisms of neutrophil accumulation in the lungs against bacteria.

Authors:  Gayathriy Balamayooran; Sanjay Batra; Michael B Fessler; Kyle I Happel; Samithamby Jeyaseelan
Journal:  Am J Respir Cell Mol Biol       Date:  2009-09-08       Impact factor: 6.914

6.  Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.

Authors:  Hiroki Kanbe; Yuji Kamijo; Takero Nakajima; Naoki Tanaka; Eiko Sugiyama; Lixuan Wang; Zhong-Ze Fang; Atsushi Hara; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Arch Toxicol       Date:  2013-09-25       Impact factor: 5.153

7.  Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.

Authors:  Apurva R Patel; Mahavir B Chougule; Townley I; Ram Patlolla; Guangdi Wang; Mandip Singh
Journal:  Pharm Res       Date:  2013-01-30       Impact factor: 4.200

8.  Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.

Authors:  Timothy B Depp; Kathleen A McGinnis; Kevin Kraemer; Kathleen M Akgün; E Jennifer Edelman; David A Fiellin; Adeel A Butt; Stephen Crystal; Adam J Gordon; Matthew Freiberg; Cynthia L Gibert; David Rimland; Kendall J Bryant; Kristina Crothers
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

Review 9.  Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Authors:  Arshad Ali Khan; Jahanzeb Mudassir; Noratiqah Mohtar; Yusrida Darwis
Journal:  Int J Nanomedicine       Date:  2013-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.